Q1 2026 Holdings
Filed 2026-05-14 | 86 holdings | $810.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $39.2M | 625,000 | 4.8% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $37.2M | 48,100 | 4.6% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $31.0M | 33,715 | 3.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $26.1M | 159,760 | 3.2% |
| CVS Health Corp(CVS) | COM | 126650100 | $24.2M | 336,500 | 3.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $23.4M | 167,750 | 2.9% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $20.3M | 41,340 | 2.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $20.0M | 109,100 | 2.5% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $19.4M | 43,485 | 2.4% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $18.6M | 1,053,450 | 2.3% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $17.0M | 36,846 | 2.1% |
| Cencora Inc(COR) | COM | 03073E105 | $16.5M | 52,375 | 2.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $15.7M | 47,800 | 1.9% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $15.6M | 71,575 | 1.9% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $15.0M | 85,300 | 1.8% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $14.6M | 16,850 | 1.8% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $14.3M | 75,890 | 1.8% |
| Guardant Health Inc(GH) | COM | 40131M109 | $13.4M | 145,000 | 1.7% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $13.3M | 100,841 | 1.6% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $13.1M | 163,000 | 1.6% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $12.6M | 24,050 | 1.6% |
| United Health Group Inc(UNH) | COM | 91324P102 | $12.3M | 45,500 | 1.5% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $11.9M | 475,000 | 1.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $11.7M | 207,000 | 1.4% |
| Abbott Laboratories(ABT) | COM | 002824100 | $11.5M | 112,000 | 1.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $11.4M | 34,465 | 1.4% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $11.2M | 233,000 | 1.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $10.8M | 63,800 | 1.3% |
| Natera Inc(NTRA) | COM | 632307104 | $10.3M | 51,600 | 1.3% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $10.2M | 54,000 | 1.3% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $10.0M | 720,000 | 1.2% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $9.9M | 155,000 | 1.2% |
| Elevance Health Inc(ELV) | COM | 036752103 | $9.5M | 32,300 | 1.2% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $9.1M | 144,500 | 1.1% |
| Glaukos Corp(GKOS) | COM | 377322102 | $9.0M | 84,000 | 1.1% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $9.0M | 53,000 | 1.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.9M | 379,250 | 1.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $8.6M | 92,605 | 1.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $8.5M | 255,500 | 1.1% |
| Pennant Group Inc(PNTG) | COM | 70805E109 | $8.4M | 275,399 | 1.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $8.3M | 81,200 | 1.0% |
| Waystar Hldg Corp(WAY) | COM | 946784105 | $8.3M | 342,566 | 1.0% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $8.0M | 1,438,625 | 1.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $7.8M | 90,000 | 1.0% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $7.6M | 660,000 | 0.9% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $7.2M | 2,055,327 | 0.9% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $7.1M | 263,071 | 0.9% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $7.0M | 92,900 | 0.9% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $6.9M | 81,627 | 0.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $6.7M | 90,600 | 0.8% |